Achieving value and sustainability in prescribing medication: consultation

Closes 8 Sep 2024

Cloral hydrate

Recommendations

  • prescribe only if for an exception or indication named in this guidance
  • consider deprescribing in individuals currently prescribed this item where appropriate
  • prescribe only if no other item or intervention is clinically appropriate
  • prescribe only if no other item or intervention is available

 

Exceptions:

  • Short term use (less than two weeks) in adults initiated by a specialist for severe insomnia, when insomnia is interfering with daily life and other therapies have failed
  • Short term use (less than two weeks) in children and adolescents with a suspected or definite neurodevelopmental disorder, which has been initiated by a specialist for severe insomnia, where the benefits of short-term use outweigh any potential risk.
  • Off-label use of chloral hydrate in the management of children and young people with movement disorders initiated and monitored by a specialist.
22a. Do you agree or disagree with the recommendation that chloral hydrate should only be prescribed for an exception or indication named in this guidance?
22b. Do you agree or disagree with the recommendation to deprescribe chloral hydrate in individuals where appropriate?
22c. Do you agree or disagree with the recommendation to only prescribe chloral hydrate if no other item or intervention is clinically appropriate or available?
22d. Please provide any further comments on the recommendations for chloral hydrate.